Value of first-line surgical treatment for classic Kaposi sarcoma and potential use of checkpoint inhibitors

J Dtsch Dermatol Ges. 2020 Mar;18(3):256-262. doi: 10.1111/ddg.14039. Epub 2020 Feb 17.
No abstract available

Publication types

  • Letter

MeSH terms

  • Aged
  • Aged, 80 and over
  • Female
  • Humans
  • Immune Checkpoint Inhibitors / therapeutic use*
  • Male
  • Sarcoma, Kaposi / surgery*
  • Skin Neoplasms / surgery*

Substances

  • Immune Checkpoint Inhibitors